LiMM Therapeutics
Developing NRILs for health
- B2B
About LiMM Therapeutics
Biopharmaceutical company developing innovative therapeutic products by deciphering neural-immune cross-talk, aimed at treating various diseases and preserving health
Key facts
- Industry
- Biotechnology Research
- Company size
- 1–10 employees
- Headquarters
- Paris, Île-de-France, France
- Founded
- 2018
- Revenue
- $3.2M – $25.6MTamtam estimate
- Website
- limmtx.com
- linkedin.com/company/neurimm
LiMM Therapeutics at a glance
LiMM Therapeutics is a B2B company in the Biotechnology Research industry, headquartered in Paris, Île-de-France, France.
LiMM Therapeutics was founded in 2018.
LiMM Therapeutics has 1–10 employees.
LiMM Therapeutics's revenue is $3.2M – $25.6M (Tamtam estimate).
Frequently asked questions about LiMM Therapeutics
What is LiMM Therapeutics's revenue?
Tamtam estimates LiMM Therapeutics's annual revenue at $3.2M – $25.6M.
How many employees does LiMM Therapeutics have?
LiMM Therapeutics has 1–10 employees.
Where is LiMM Therapeutics headquartered?
LiMM Therapeutics is headquartered in Paris, Île-de-France, France.
Selling to companies like LiMM Therapeutics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies